News AZ partners with Aptar on kidney disease-detecting AI AstraZeneca has turned to another digital health partner to support its aspirations in chronic kidney disease (CKD).
Digital Frontiers Health Digital Innovators: Aptar’s Sai Shankar Continuing his Frontiers Health Digital Innovator's series, pharmaphorum’s founder, Dr Paul Tunnah, speaks with president of Digital Health Sai Shankar. At Frontiers Health
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
